CHAR Technologies (YES) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Jun, 2025Executive summary
Achieved significant progress on the Thorold Renewable Energy Facility, with commercial biocarbon production targeted for Q4 2025 and a new strategic partnership with BMI Group to accelerate commercialization and expand project pipeline.
Completed the divestiture of consulting operations to focus on core Build-Own-Operate (BOO) projects, streamlining operations and improving financial performance.
Launched a U.S.-based high-temperature pyrolysis (HTP) demonstration project for PFAS destruction, marking entry into the U.S. market and expanding commercial opportunities.
Secured over C$19 million in funding commitments, including government grants and strategic investments from partners like ArcelorMittal and BMI Group.
Advanced multiple projects in Ontario and Québec, including Lake Nipigon and Saint-Félicien, with strong government and industry support.
Financial highlights
Revenue from continuing operations for the quarter ended March 31, 2025 was $726,968, up from $708,760 in the same quarter last year.
Gross profit increased to $269,997 from $3,331 year-over-year, driven by higher-margin feasibility studies.
Net loss from continuing operations narrowed to $1,547,308 (loss per share $0.01) from $2,244,352 (loss per share $0.02) in the prior year quarter.
Grant income of $298,244 recognized in the quarter, compared to nil in the same period last year.
Cash balance as of March 31, 2025 was $1,206,403, up from $948,689 at September 30, 2024.
Outlook and guidance
Commercial biocarbon production at Thorold facility targeted for Q4 2025, with BMI Group partnership supporting construction and commissioning.
Ongoing expansion of project pipeline, including new facilities in Espanola, Ontario and continued development in Lake Nipigon and Saint-Félicien.
Extended testing of HTP system for PFAS destruction in the U.S. through December 2025, with potential for broader adoption.
Management anticipates sufficient funding for operations through fiscal 2025, with continued focus on securing project-level financing.
Latest events from CHAR Technologies
- Five-facility pipeline targets $131M revenue, $42M free cash flow, and global PFAS licensing upside.YES
Corporate presentation23 Apr 2026 - Thorold commissioning and global tech validation drive strong revenue and growth outlook.YES
Status update18 Feb 2026 - Commercialization and new investments drove equity gains and global technology milestones.YES
Q4 202517 Feb 2026 - Scaling renewable gas and biocarbon with strong partners and robust project economics.YES
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Net loss widened as focus shifted to BOO projects, with Thorold facility funding secured.YES
Q3 202523 Sep 2025 - Net loss widened to $6.06M as liquidity risks persist despite grant funding and new loans.YES
Q3 202413 Jun 2025 - Revenue up, losses narrowed, and focus shifts to cleantech amid new funding and project risks.YES
Q1 20256 Jun 2025 - Net loss deepened as CharTech exited consulting, but new funding boosts renewable project focus.YES
Q4 20246 Jun 2025